Clementia Pharmaceuticals appoints

Clementia Pharmaceuticals, a privately held clinical stage biotechnology company has appointed three key executives with rare disease and orphan drug expertise: Donna Grogan, M.D., as chief medical officer, Jeff Packman as chief development officer and Eric Grinstead as chief commercial officer. The company is backed by OrbiMed Advisors and BDC Venture Capital.

PeopleNorth AmericaUSBriefs